[{"data":1,"prerenderedAt":207},["ShallowReactive",2],{"drug-venlafaxine":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":12,"synonyms":16,"formulations":19,"regimens":50,"contraindications":77,"warnings":87,"renal":88,"monitoring":89,"interactions":90,"review":91,"examples":94,"atc":100,"iran":102,"links":150,"populations":167,"usApproval":202},"venlafaxine",1,{"fa":7,"en":8},"ونلافاکسین","Venlafaxine","nervous-system",{"fa":11,"en":11},"SNRI",[13],{"name":14,"market":15},"Effexor XR","US",[17,18,7],"effexor","افکسور",[20,34,42],{"id":21,"form":22,"route":23,"label":24,"concentration":25,"markets":29,"refs":30},"cap-37-5","capsule","oral","37.5 mg capsule",{"amount":26,"unit":27,"perUnit":22,"scored":28},37.5,"mg",false,[15],[31],{"source":32,"section":33},"fda-venlafaxine-xr","3",{"id":35,"form":22,"route":23,"label":36,"concentration":37,"markets":39,"refs":40},"cap-75","75 mg capsule",{"amount":38,"unit":27,"perUnit":22,"scored":28},75,[15],[41],{"source":32,"section":33},{"id":43,"form":22,"route":23,"label":44,"concentration":45,"markets":47,"refs":48},"cap-150","150 mg capsule",{"amount":46,"unit":27,"perUnit":22,"scored":28},150,[15],[49],{"source":32,"section":33},[51],{"id":52,"disease":52,"label":53,"population":56,"type":60,"unit":27,"dose":61,"refs":65,"notes":68},"mdd",{"fa":54,"en":55},"افسردگی — بزرگسال: ۷۵ mg روزانه","MDD — adults: 75 mg daily",{"minAge":57},{"value":58,"unit":59},18,"year","titration",{"dividedDoses":5,"titration":62},{"start":38,"increment":38,"incrementEveryDays":63,"targetMin":38,"targetMax":64,"max":64},4,225,[66],{"source":32,"section":67},"2.2",[69],{"text":70,"refs":73},{"fa":71,"en":72},"برخی بیماران: ۳۷٫۵ mg به مدت ۴ تا ۷ روز سپس ۷۵. همراه غذا؛ کپسول باز نشود.","Some patients: 37.5 mg for 4–7 days then 75. With food; do not open capsule.",[74,75],{"source":32,"section":67},{"source":32,"section":76},"2.1",[78],{"id":79,"severity":80,"text":81,"refs":84},"maoi","block",{"fa":82,"en":83},"MAOI (شامل لینزولید یا متیلن بلو وریدی) یا تا ۱۴ روز پس از قطع.","MAOI (incl. linezolid or IV methylene blue) or within 14 days.",[85],{"source":32,"section":86},"4",[],[],[],[],{"status":92,"reviewer":93,"date":93},"unverified",null,[95],{"regimen":52,"formulation":35,"input":96,"expect":99},{"ageYears":97,"weightKg":98},30,70,{"perDose":38},[101],"N06AX16",{"status":103,"forms":104,"refs":145},"registered",[105,109,113,117,121,125,129,133,137,141],{"code":106,"en":107,"fa":108},"09557","VENLAFAXINE 100MCG TAB","قرص ونلافاکسین ۱۰۰ میکروگرم",{"code":110,"en":111,"fa":112},"05154","VENLAFAXINE 150MG EXTENDED RELEASE CAP","کپسول آهسته‌رهش ونلافاکسین ۱۵۰ میلی‌گرم",{"code":114,"en":115,"fa":116},"09713","VENLAFAXINE 150MG TAB","قرص ونلافاکسین ۱۵۰ میلی‌گرم",{"code":118,"en":119,"fa":120},"05791","VENLAFAXINE 37.5MG CAP","کپسول ونلافاکسین ۳۷٫۵ میلی‌گرم",{"code":122,"en":123,"fa":124},"16035","VENLAFAXINE 37.5MG EXTENDED RELEASE CAP","کپسول آهسته‌رهش ونلافاکسین ۳۷٫۵ میلی‌گرم",{"code":126,"en":127,"fa":128},"07932","VENLAFAXINE 37.5MG TAB","قرص ونلافاکسین ۳۷٫۵ میلی‌گرم",{"code":130,"en":131,"fa":132},"14404","VENLAFAXINE 50MG TAB","قرص ونلافاکسین ۵۰ میلی‌گرم",{"code":134,"en":135,"fa":136},"05155","VENLAFAXINE 75MG CAP","کپسول ونلافاکسین ۷۵ میلی‌گرم",{"code":138,"en":139,"fa":140},"13873","VENLAFAXINE 75MG EXTENDED RELEASE CAP","کپسول آهسته‌رهش ونلافاکسین ۷۵ میلی‌گرم",{"code":142,"en":143,"fa":144},"06631","VENLAFAXINE 75MG TAB","قرص ونلافاکسین ۷۵ میلی‌گرم",[146],{"source":147,"section":148,"url":149},"darooyab-generic","G-617\u002FVenlafaxine","https:\u002F\u002Fwww.darooyab.ir\u002FG-617\u002FVenlafaxine",[151,155,159,162,165],{"kind":152,"url":153,"label":154},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=200834","ANDA200834",{"kind":156,"url":157,"label":158},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=7588ffdc-034d-4baf-9889-9a0ded265be5","FDA Venlafaxine XR",{"kind":160,"url":161,"label":8},"medlineplus","https:\u002F\u002Fmedlineplus.gov\u002Fdruginfo\u002Fmeds\u002Fa694020.html",{"kind":163,"url":164,"label":101},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=N06AX16",{"kind":166,"url":149,"label":8},"darooyab",{"pregnancy":168,"lactation":177,"pediatric":185,"geriatric":194},{"level":169,"text":170,"quote":173,"refs":174},"caution",{"fa":171,"en":172},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Risk Summary Based on data from published observational studies, exposure to SNRIs, particularly in the month before delivery, has been associated with a less than 2-fold increase in the risk of postpartum hemorrhage [see Warnings and Precautions (5.4) and Clinical Considerations] .",[175],{"source":32,"section":176},"8.1",{"level":169,"text":178,"quote":181,"refs":182},{"fa":179,"en":180},"برچسب: در شیردهی با احتیاط؛ متن برچسب را ببینید.","Label: use with caution while breastfeeding; see the label text.","Risk Summary Data from published literature report the presence of venlafaxine and its active metabolite in human milk and have not shown adverse reactions in breastfed infants (see Data) .",[183],{"source":32,"section":184},"8.2",{"level":186,"text":187,"quote":190,"refs":191},"avoid",{"fa":188,"en":189},"هشدار جعبه‌ای برچسب درباره کودکان.","Boxed warning in the label about children.","Antidepressants increased the risk of suicidal thoughts and behavior in pediatric and young adult patients in short-term studies.",[192],{"source":32,"section":193},"Boxed Warning",{"level":169,"text":195,"quote":198,"refs":199},{"fa":196,"en":197},"برچسب: در سالمندان با احتیاط و معمولاً از دوز پایین شروع شود.","Label: use with caution in older adults, usually starting at the low end of the dose range.","… ly significant hyponatremia in elderly patients, who may be at greater risk for this adverse event [see Warnings and Precautions (5.9) ] .",[200],{"source":32,"section":201},"8.5",{"kind":203,"refs":204,"id":154},"ANDA",[205],{"source":32,"section":206},"SPL approval \u002F marketing category",1792444714923]